We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

World’s First Rapid Saliva-Based Pregnancy Test Set for Multi-Country Launch

By LabMedica International staff writers
Posted on 09 Nov 2022

Saliva contains over 5,000 identified proteins. With significant overlap to blood, saliva is considered the second most important body-fluid for diagnostics. Now, the world’s first saliva-based pregnancy test is all set to arrive in stores across Europe, South Africa, United Arab Emirates, and Israel in the first quarter of 2023. By analyzing saliva, the test completely removes the need for blood and urine samples when testing for pregnancy.

Salistick from Salignostics (Jerusalem, Israel) is the first rapid saliva-based pregnancy test with a new and improved user-experience, and high accuracy for early pregnancy detection. The kit is based on the company’s revolutionary technology which opens the door for a sensitive detection of the pregnancy hormone β-hCG in saliva. The simple, easy to use test can be done anywhere, at any time, without the need for a restroom and delivers accurate results in no more than 10 minutes.


Image: SaliStick is the first pregnancy test that does not require urine (Photo courtesy of Salignostics)
Image: SaliStick is the first pregnancy test that does not require urine (Photo courtesy of Salignostics)

Salistick has already been approved by the European CE certification and has received Medical Devices and Accessories approval from Israel’s Ministry of Health. Salignostics has also completed a 510(K) initial Q-submission of SaliStick to the US FDA. In order to support the commercialization of SaliStick, Salignostics has established a new manufacturing facility in Israel with a monthly production capacity of one million units.

Related Links:
Salignostics 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Plasma Control
Plasma Control Level 1

Latest Molecular Diagnostics News

Urine Test to Revolutionize Lyme Disease Testing

Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease

New Genetic Testing Procedure Combined With Ultrasound Detects High Cardiovascular Risk